# A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers

> **NCT01755247** · PHASE1 · COMPLETED · sponsor: **Novan, Inc.** · enrollment: 15 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Topical Gel Vehicle
- **DRUG:** 8% NVN1000 Topical Gel
- **DRUG:** 8% NVN1000 Topical Gel and moisturizer

## Key facts

- **NCT ID:** NCT01755247
- **Lead sponsor:** Novan, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2012-11
- **Final completion:** 2012-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2019-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01755247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01755247, "A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01755247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*